XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF REVENUE FROM PRODUCT SALES AND ROYALTIES (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Product Information [Line Items]        
Total Net Revenue $ 16,024,948 $ 13,044,571 $ 47,300,029 $ 30,526,572
Soft Tissue Repair Products [Member]        
Product Information [Line Items]        
Total Net Revenue 13,634,316 10,969,271 39,756,539 28,296,919
Bone Fusion Products [Member]        
Product Information [Line Items]        
Total Net Revenue 2,340,382 2,025,050 7,392,740 2,078,903
Royalty [Member]        
Product Information [Line Items]        
Total Net Revenue $ 50,250 $ 50,250 $ 150,750 $ 150,750